Closed
SectorHealthcare
435 -0.28
24h
Min
434.23
Max
441.09
Income | 31M -42M |
---|---|
Sales | 76M 213M |
EPS | -1.9 |
Profit margin | -19.869 |
Employees | 528 |
EBITDA | 31M -39M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +10.73% upside |
Next Earnings | 30 paź 2025 |
---|
Market Cap | 2.9B 9.9B |
---|---|
Previous open | 435.28 |
Previous close | 435 |
By Acuity
29%
71%
96 / 371 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 483.08 USD 10.73%
High 567 USD
Low 266 USD
Based on 15 Wall Street analysts offering 12 month price targets forMadrigal Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$